BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Non-Complex Biliary Stones DSC vs ERC

Not Applicable

Completed

Conditions: Biliary Stones

Interventions: Device: DSC
Device: ERC

First Posted Date: 2018-02-05

Last Posted Date: 2024-11-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 250

Registration Number: NCT03421340

Locations: 🇺🇸
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
🇺🇸
University of Colorado Hospital, Denver, Aurora, Colorado, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States

and more 5 locations

Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema

Not Applicable

Completed

Conditions: Emphysema

Interventions: Device: Endobronchial Coils

First Posted Date: 2017-12-04

Last Posted Date: 2023-08-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 120

Registration Number: NCT03360396

Locations: 🇫🇷
CHU Grenoble, Grenoble, France
🇦🇹
Ludwig Boltzmann Institut Fur COPD und pneumologische Epidemologie, Wien, Austria
🇫🇷
Centre Hospitalier Universitaire de Nice, Nice, France

and more 16 locations

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: SYNERGY 48 mm

First Posted Date: 2017-11-22

Last Posted Date: 2021-05-14

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT03350542

Locations: 🇺🇸
HealthEast St. Joseph's Hospital, Saint Paul, Minnesota, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇱🇻
P. Stradins University Hospital, Riga, Latvia

and more 12 locations

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Device: TheraSphere

First Posted Date: 2017-09-27

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 209

Registration Number: NCT03295006

Locations: 🇸🇦
King Faisal Hospital, Riyad, Saudi Arabia
🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇺🇸
Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States

and more 11 locations

Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies

Early Phase 1

Completed

Conditions: Carcinoma, Hepatocellular
Metastatic Colorectal Cancer

Interventions: Drug: BTG-002814

First Posted Date: 2017-09-25

Last Posted Date: 2021-07-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 8

Registration Number: NCT03291379

Locations: 🇬🇧
University College London Hospital, Bloomsbury, London, United Kingdom

PROMUS PREMIER™ China Post-Approval Study

Active, not recruiting

Conditions: Coronary Artery Disease

First Posted Date: 2017-09-06

Last Posted Date: 2024-11-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2059

Registration Number: NCT03273023

Locations: 🇨🇳
The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014

Terminated

Conditions: COPD Symptoms After Coil Procedure

First Posted Date: 2017-08-31

Last Posted Date: 2021-07-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 9

Registration Number: NCT03267992

Locations: 🇨🇭
Hôpitaux Universitaires de Genève (HUG) Service, Genève, Switzerland
🇨🇭
UniversitätsSpital, Zürich, Switzerland

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)

Completed

Conditions: Venous Leg Ulcer

First Posted Date: 2017-08-22

Last Posted Date: 2021-12-14

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 76

Registration Number: NCT03257254

Locations: 🇺🇸
Pines Clinical Research, Aventura, Florida, United States
🇨🇦
Oakville Vascular, Oakville, Ontario, Canada
🇺🇸
OhioHealth Research, Columbus, Ohio, United States

and more 11 locations

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)

Not Applicable

Completed

Conditions: Left Ventricular Dysfunction

Interventions: Device: CRT-D

First Posted Date: 2017-08-22

Last Posted Date: 2022-01-03

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 586

Registration Number: NCT03257436

Locations: 🇺🇸
MedStar Heart and Vascular Institute, Baltimore, Maryland, United States
🇺🇸
AnMed Health Clinical Research, Anderson, South Carolina, United States
🇺🇸
Deborah Heart and Lung Center, Browns Mills, New Jersey, United States

and more 51 locations

Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System

Not Applicable

Completed

Conditions: Chronic Pain
Back Pain

Interventions: Device: Spectra WaveWriter SCS System

First Posted Date: 2017-08-16

Last Posted Date: 2021-04-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 97

Registration Number: NCT03251937

Locations: 🇺🇸
Mercy Medical Research Institute, Springfield, Missouri, United States
🇺🇸
University Hospitals of Cleveland, Cleveland, Ohio, United States
🇺🇸
University of Rochester, Rochester, New York, United States

and more 12 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy